{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T11:57:59Z","timestamp":1774007879648,"version":"3.50.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.ijpharm.2015.07.013","type":"journal-article","created":{"date-parts":[[2015,7,11]],"date-time":"2015-07-11T04:04:52Z","timestamp":1436587492000},"page":"65-72","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":98,"title":["Optimization of nanostructured lipid carriers loaded with methotrexate: A tool for inflammatory and cancer therapy"],"prefix":"10.1016","volume":"492","author":[{"given":"Mara","family":"Ferreira","sequence":"first","affiliation":[]},{"given":"Lu\u00edse L.","family":"Chaves","sequence":"additional","affiliation":[]},{"given":"Sofia A. Costa","family":"Lima","sequence":"additional","affiliation":[]},{"given":"Salette","family":"Reis","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/j.ijpharm.2015.07.013_bib0005","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1007\/s00280-012-2062-0","article-title":"A review of therapeutic challenges and achievements of methotrexate delivery systems for treatment of cancer and rheumatoid arthritis","volume":"71","author":"Abolmaali","year":"2013","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.ijpharm.2015.07.013_bib0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev-bioeng-071811-150124","article-title":"The effect of nanoparticle size shape, and surface chemistry on biological systems","volume":"14","author":"Albanese","year":"2012","journal-title":"Annu. Rev. Biomed. Eng."},{"key":"10.1016\/j.ijpharm.2015.07.013_bib0015","doi-asserted-by":"crossref","first-page":"167","DOI":"10.18433\/J3D59T","article-title":"Kinetic analysis of drug release from nanoparticles","volume":"11","author":"Barzegar-Jalali","year":"2008","journal-title":"J. Pharm. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2015.07.013_bib0020","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1097\/BOR.0b013e328329c79d","article-title":"An update on methotrexate","volume":"21","author":"Braun","year":"2009","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.ijpharm.2015.07.013_bib0025","doi-asserted-by":"crossref","first-page":"199","DOI":"10.4155\/ppa.13.79","article-title":"Pharmaceutical and biomedical applications of lipid-based nanocarriers","volume":"3","author":"Carbone","year":"2014","journal-title":"Pharm. Pat. Anal."},{"key":"10.1016\/j.ijpharm.2015.07.013_bib0030","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ejpb.2010.11.008","article-title":"High loading efficiency and sustained release of siRNA encapsulated in PLGA nanoparticles: quality by design optimization and characterization","volume":"77","author":"Cun","year":"2011","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2015.07.013_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.actbio.2015.02.007","article-title":"Precise engineering of dapivirine-loaded nanoparticles for the development of anti-HIV vaginal microbicides","author":"das Neves","year":"2015","journal-title":"Acta Biomater."},{"key":"10.1016\/j.ijpharm.2015.07.013_bib0040","first-page":"217","article-title":"Kinetic modeling on drug release from controlled drug delivery systems","volume":"67","author":"Dash","year":"2010","journal-title":"Acta Pol. Pharm."},{"key":"10.1016\/j.ijpharm.2015.07.013_bib0045","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0162-3109(00)00189-2","article-title":"Mechanism of action of methotrexate","volume":"47","author":"Genestier","year":"2000","journal-title":"Immunol. Pharmacol."},{"key":"10.1016\/j.ijpharm.2015.07.013_bib0050","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0168-3659(97)00102-8","article-title":"Formulation optimization of controlled release diclofenac sodium microspheres using factorial design","volume":"51","author":"Gohel","year":"1998","journal-title":"J. Controlled Release"},{"key":"10.1016\/j.ijpharm.2015.07.013_bib0055","first-page":"683","article-title":"Development and optimization of solid lipid nanoparticle formulation for ophthalmic delivery of chloramphenicol using a Box\u2013Behnken design","volume":"6","author":"Hao","year":"2011","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ijpharm.2015.07.013_bib0060","doi-asserted-by":"crossref","first-page":"4283","DOI":"10.1016\/S0142-9612(03)00331-4","article-title":"Physico-chemical stability of colloidal lipid particles","volume":"24","author":"Heurtault","year":"2003","journal-title":"Biomaterials"},{"key":"10.1016\/j.ijpharm.2015.07.013_bib0065","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1111\/j.1745-7254.2008.00829.x","article-title":"Development and evaluation of lipid nanoparticles for camptothecin delivery: a comparison of solid lipid nanoparticles, nanostructured lipid carriers, and lipid emulsion","volume":"29","author":"Huang","year":"2008","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ijpharm.2015.07.013_bib0070","doi-asserted-by":"crossref","first-page":"499","DOI":"10.18388\/abp.2010_2435","article-title":"Methotrexate binding causes structural and functional changes in lung cystatin","volume":"57","author":"Khan","year":"2010","journal-title":"Acta Biochim. Pol."},{"key":"10.1016\/j.ijpharm.2015.07.013_bib0075","doi-asserted-by":"crossref","first-page":"8858","DOI":"10.1021\/la0503451","article-title":"Methotrexate-modified superparamagnetic nanoparticles and their intracellular uptake into human cancer cells","volume":"21","author":"Kohler","year":"2005","journal-title":"Langmuir"},{"key":"10.1016\/j.ijpharm.2015.07.013_bib0080","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ijpharm.2003.10.038","article-title":"Potential use of nanoparticles for transcutaneous vaccine delivery: effect of particle size and charge","volume":"275","author":"Kohli","year":"2004","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2015.07.013_bib0085","first-page":"117","article-title":"Combination of calcipotriol and methotrexate in nanostructured lipid carriers for topical delivery","volume":"5","author":"Lin","year":"2010","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ijpharm.2015.07.013_bib0090","doi-asserted-by":"crossref","first-page":"751","DOI":"10.3109\/03639040903460453","article-title":"Characterization and formulation optimization of solid lipid nanoparticles in vitamin K1 delivery","volume":"36","author":"Liu","year":"2010","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ijpharm.2015.07.013_bib0095","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.cis.2013.11.018","article-title":"Niosomes from 80s to present: the state of the art","volume":"205","author":"Marianecci","year":"2014","journal-title":"Adv. Colloid Interface Sci."},{"key":"10.1016\/j.ijpharm.2015.07.013_bib0100","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.ijpharm.2011.05.008","article-title":"Lipid nanocarriers for dermal delivery of lutein: preparation, characterization, stability and performance","volume":"414","author":"Mitri","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2015.07.013_bib0105","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0939-6411(00)00087-4","article-title":"Solid lipid nanoparticles (SLN) for controlled drug delivery \u2013 a review of the state of the art","volume":"50","author":"M\u00fcller","year":"2000","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2015.07.013_bib0110","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.mrgentox.2008.11.011","article-title":"Methotrexate-induced cytotoxicity and genotoxicity in germ cells of mice: intervention of folic and folinic acid","volume":"673","author":"Padmanabhan","year":"2009","journal-title":"Mutat. Res."},{"key":"10.1016\/j.ijpharm.2015.07.013_bib0115","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.ijpharm.2008.10.003","article-title":"Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products","volume":"366","author":"Pardeike","year":"2009","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2015.07.013_bib0120","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.ijpharm.2014.10.067","article-title":"A new topical formulation for psoriasis: development of methotrexate-loaded nanostructured lipid carriers","volume":"477","author":"Pinto","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2015.07.013_bib0125","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.chemphyslip.2014.11.004","article-title":"Development characterization and skin permeating potential of lipid based novel delivery system for topical treatment of psoriasis","volume":"186","author":"Pradhan","year":"2015","journal-title":"Chem. Phys. Lipids"},{"issue":"1","key":"10.1016\/j.ijpharm.2015.07.013_bib0130","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ejpb.2010.05.003","article-title":"Non-destructive methods of characterization of risperidone solid lipid nanoparticles","volume":"76","author":"Rahman","year":"2010","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"4","key":"10.1016\/j.ijpharm.2015.07.013_bib0135","first-page":"473","article-title":"Methotrexate in rheumatoid arthritis","volume":"58","author":"Swierkot","year":"2006","journal-title":"Pharmacol. Rep."},{"issue":"5","key":"10.1016\/j.ijpharm.2015.07.013_bib0140","first-page":"375","article-title":"Preparation, characterization and physico-chemical properties of solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC): their benefits as colloidal drug carrier systems","volume":"61","author":"Uner","year":"2006","journal-title":"Pharmazie"},{"issue":"6","key":"10.1016\/j.ijpharm.2015.07.013_bib0145","first-page":"1017","article-title":"Risk and management of liver toxicity during methotrexate treatment in rheumatoid and psoriatic arthritis: a systematic review of the literature","volume":"27","author":"Visser","year":"2009","journal-title":"Clin. Exp. Rheumatol."}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517315300314?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517315300314?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T02:17:54Z","timestamp":1656641874000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517315300314"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":29,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["S0378517315300314"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2015.07.013","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimization of nanostructured lipid carriers loaded with methotrexate: A tool for inflammatory and cancer therapy","name":"articletitle","label":"Article Title"},{"value":"International Journal of Pharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpharm.2015.07.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}